NeurogesX, Inc. (NGSX) Posts Q3 Loss of 43c/Share

NeurogesX, Inc. (NASDAQ: NGSX) reported Q3 loss of ($0.43), $0.01 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.89 million versus the consensus estimate of $3.14 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance